Topic Highlight
Copyright ©The Author(s) 2016.
World J Gastroenterol. Feb 14, 2016; 22(6): 1966-1974
Published online Feb 14, 2016. doi: 10.3748/wjg.v22.i6.1966
Figure 2
Figure 2 Anti-rods and rings autoantibody production in patients with chronic hepatitis C virus infection. Ribavirin therapy leads cells to present RR structures, while interferon-α stimulates the host immune system. These factors, plus others yet to be confirmed, could contribute to the tolerance breakdown with autoantibody production against RR structures, whose levels increase during treatment. RR: Rods and rings; HCV: Hepatitis C virus; IFN: Interferon.